{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:43:30Z","timestamp":1742913810761,"version":"3.40.3"},"publisher-location":"Cham","reference-count":172,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030319410"},{"type":"electronic","value":"9783030319427"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/7081_2019_31","type":"book-chapter","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T21:25:16Z","timestamp":1550870716000},"page":"171-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recent Advances in the Chemistry and Biology of Spirocyclic Nucleosides"],"prefix":"10.1007","author":[{"given":"Mart\u00edn","family":"Soto","sequence":"first","affiliation":[]},{"given":"Humberto","family":"Rodr\u00edguez-Solla","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Soengas","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,2,24]]},"reference":[{"key":"31_CR1","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1021\/jm900932g","volume":"53","author":"E Clercq de","year":"2010","unstructured":"de Clercq E (2010) Highlights in the discovery of antiviral drugs: a personal retrospective. J Med Chem 53:1438\u20131450. \n https:\/\/doi.org\/10.1021\/jm900932g","journal-title":"J Med Chem"},{"key":"31_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1021\/jm900492g","volume":"53","author":"Y Mehellou","year":"2010","unstructured":"Mehellou Y, De Clercq E (2010) Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go? J Med Chem 53:521\u2013538. \n https:\/\/doi.org\/10.1021\/jm900492g","journal-title":"J Med Chem"},{"key":"31_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/rmv.624","volume":"19","author":"E Clercq de","year":"2009","unstructured":"de Clercq E (2009) The history of antiretrovirals: key discoveries over the past 25\u00a0years. Rev Med Virol 19:287\u2013299. \n https:\/\/doi.org\/10.1002\/rmv.624","journal-title":"Rev Med Virol"},{"key":"31_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-3527(09)73001-5","volume":"73","author":"E Clercq de","year":"2009","unstructured":"de Clercq E (2009) Looking back in 2009 at the dawning of antiviral therapy now 50\u00a0years ago in historical perspective. Adv Virus Res 73:1\u201353. \n https:\/\/doi.org\/10.1016\/S0065-3527(09)73001-5","journal-title":"Adv Virus Res"},{"key":"31_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.antiviral.2009.10.005","volume":"85","author":"E Clercq De","year":"2010","unstructured":"De Clercq E (2010) In search of a selective therapy of viral infections. Antivir Res 85:19\u201324. \n https:\/\/doi.org\/10.1016\/j.antiviral.2009.10.005","journal-title":"Antivir Res"},{"key":"31_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/01.cco.0000245326.65152.af","volume":"18","author":"V Gandhi","year":"2006","unstructured":"Gandhi V, Plunkett W (2006) Clofarabine and nelarabine: two new purine nucleoside analogs. Curr Opin Oncol 18:584\u2013590. \n https:\/\/doi.org\/10.1097\/01.cco.0000245326.65152.af","journal-title":"Curr Opin Oncol"},{"key":"31_CR7","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.2174\/1381612033453677","volume":"9","author":"GH Elgemeie","year":"2003","unstructured":"Elgemeie GH (2003) Thioguanine, mercaptopurine: their analogs and nucleosides as antimetabolites. Curr Pharm Des 9:2627\u20132642. \n https:\/\/doi.org\/10.2174\/1381612033453677","journal-title":"Curr Pharm Des"},{"key":"31_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2174\/1381612033453677","volume":"5","author":"S Miura","year":"2004","unstructured":"Miura S, Izuta S (2004) DNA polymerases as targets of anticancer nucleosides. Curr Drug Targets 5:191\u2013195. \n https:\/\/doi.org\/10.2174\/1381612033453677","journal-title":"Curr Drug Targets"},{"key":"31_CR9","first-page":"592","volume":"5","author":"WB Parker","year":"2004","unstructured":"Parker WB, Secrist JA, Waud WR (2004) Purine nucleoside antimetabolites in development for the treatment of cancer. Curr Opin Investig Drugs 5:592\u2013596","journal-title":"Curr Opin Investig Drugs"},{"key":"31_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2174\/1568012033483042","volume":"2","author":"C Ying","year":"2003","unstructured":"Ying C, de Clercq E, Neyts J (2003) Selective inhibitors of hepatitis B virus replication. Curr Med Chem Anti-Infect Agents 2:227\u2013240. \n https:\/\/doi.org\/10.2174\/1568012033483042","journal-title":"Curr Med Chem Anti-Infect Agents"},{"key":"31_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2174\/1568026043388484","volume":"4","author":"PL Sharma","year":"2004","unstructured":"Sharma PL, Nurpeisov V, Hernandez-Santiago B, Beltran T, Schinazi RF (2004) Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Curr Top Med Chem 4:895\u2013921. \n https:\/\/doi.org\/10.2174\/1568026043388484","journal-title":"Curr Top Med Chem"},{"key":"31_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.coph.2004.06.001","volume":"4","author":"M Otto","year":"2004","unstructured":"Otto M (2004) New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections. Curr Opin Pharmacol 4:431\u2013436. \n https:\/\/doi.org\/10.1016\/j.coph.2004.06.001","journal-title":"Curr Opin Pharmacol"},{"key":"31_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2174\/0929867013373471","volume":"8","author":"E Ichikawa","year":"2001","unstructured":"Ichikawa E, Kato K (2001) Sugar-modified nucleosides in past 10\u00a0years, a review. Curr Med Chem 8:385\u2013423. \n https:\/\/doi.org\/10.2174\/0929867013373471","journal-title":"Curr Med Chem"},{"key":"31_CR14","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1021\/bi992112c","volume":"39","author":"H Ford","year":"2000","unstructured":"Ford H, Dai F, Mu L, Siddiqui MA, Nicklaus MC, Anderson L, Marquez VE, Barchi JJ (2000) Adenosine deaminase prefers a distinct sugar ring conformation for binding and catalysis: kinetic and structural studies. Biochemistry 39:2581\u20132592. \n https:\/\/doi.org\/10.1021\/bi992112c","journal-title":"Biochemistry"},{"key":"31_CR15","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1016\/S0968-0896(02)00099-8","volume":"10","author":"S Hernandez","year":"2002","unstructured":"Hernandez S, Ford H, Marquez VE (2002) Is the anomeric effect an important factor in the rate of adenosine deaminase catalyzed hydrolysis of purine nucleosides? A direct comparison of nucleoside analogues constructed on ribose and carbocyclic templates with equivalent heterocyclic bases selected to promote hydration. Bioorg Med Chem 10:2723\u20132730. \n https:\/\/doi.org\/10.1016\/S0968-0896(02)00099-8","journal-title":"Bioorg Med Chem"},{"key":"31_CR16","doi-asserted-by":"publisher","first-page":"15145","DOI":"10.1021\/ja053789s","volume":"127","author":"VE Marquez","year":"2005","unstructured":"Marquez VE, Choi Y, Comin MJ, Russ P, George C, Huleihel M, Ben-Kasus T, Agbaria R (2005) Understanding how the herpes thymidine kinase orchestrates optimal sugar and nucleobase conformations to accommodate its substrate at the active site: a chemical approach. J Am Chem Soc 127:15145\u201315150. \n https:\/\/doi.org\/10.1021\/ja053789s","journal-title":"J Am Chem Soc"},{"key":"31_CR17","doi-asserted-by":"publisher","first-page":"8103","DOI":"10.1021\/jm050726b","volume":"48","author":"S Costanzi","year":"2005","unstructured":"Costanzi S, Joshi BV, Maddileti S, Mamedova L, Gonzalez-Moa MJ, Marquez VE, Harden TK, Jacobson KA (2005) Semirational design of (north)-methanocarba nucleosides as dual acting A1 and A3 adenosine receptor agonist: novel prototypes for cardioprotection. J Med Chem 48:8103\u20138107. \n https:\/\/doi.org\/10.1021\/jm050726b","journal-title":"J Med Chem"},{"key":"31_CR18","doi-asserted-by":"publisher","first-page":"8108","DOI":"10.1021\/jm050911p","volume":"48","author":"P Besada","year":"2005","unstructured":"Besada P, Shin DH, Costanzi S, Ko H, Math\u00e9 C, Gagneron J, Gosselin G, Maddileti S, Harden TK (2005) Human P2Y6 receptor: molecular modeling leads to the rational design of a novel agonist base on a unique conformational preference. J Med Chem 48:8108\u20138111. \n https:\/\/doi.org\/10.1021\/jm050911p","journal-title":"J Med Chem"},{"key":"31_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jmb.2004.10.021","volume":"345","author":"PL Boyer","year":"2005","unstructured":"Boyer PL, Julias JG, Marquez VE, Hugues SH (2005) Fixed conformation nucleoside analogues effectively inhibit excision-proficient HIV-1 reverse transcriptases. J Mol Biol 345:441\u2013450. \n https:\/\/doi.org\/10.1016\/j.jmb.2004.10.021","journal-title":"J Mol Biol"},{"key":"31_CR20","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1021\/jm060485n","volume":"49","author":"P Besada","year":"2006","unstructured":"Besada P, Shin DH, Costanzi S, Ko H, Math\u00e9 C, Gagneron J, Gosselin G, Maddileti S, Harden TK, Jacobson KA (2006) Structure-activity relationships of uridine 5\u2032-diphosphate analogues at the human P2Y6 receptor. J Med Chem 49:5532\u20135543. \n https:\/\/doi.org\/10.1021\/jm060485n","journal-title":"J Med Chem"},{"key":"31_CR21","doi-asserted-by":"publisher","first-page":"8205","DOI":"10.1021\/ja00778a043","volume":"94","author":"C Altona","year":"1972","unstructured":"Altona C, Sundaralingam M (1972) Conformational analysis of the sugar ring in nucleosides and nucleotides. New description using the concept of pseudorotation. J Am Chem Soc 94:8205\u20138212. \n https:\/\/doi.org\/10.1021\/ja00778a043","journal-title":"J Am Chem Soc"},{"key":"31_CR22","doi-asserted-by":"publisher","unstructured":"Math\u00e9 C, P\u00e9rigaud C (2008) Recent approaches in the synthesis of conformationally restricted nucleoside analogues. Eur J Org Chem 1489\u20131505. \n https:\/\/doi.org\/10.1002\/ejoc.200700946","DOI":"10.1002\/ejoc.200700946"},{"key":"31_CR23","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1021\/jo015602v","volume":"66","author":"L Kvaerna","year":"2001","unstructured":"Kvaerna L, Wightman R, Wengel J (2001) Synthesis of a novel bicyclic nucleoside restricted to an S-type conformation and initial evaluation of its hybridization properties when incorporated into oligodeoxynucleotides. J Org Chem 66:5106\u20135112. \n https:\/\/doi.org\/10.1021\/jo015602v","journal-title":"J Org Chem"},{"key":"31_CR24","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1016\/j.tet.2004.03.019","volume":"60","author":"M Freitag","year":"2004","unstructured":"Freitag M, Thomasen H, Christensen N, Petersen M, Nielsen P (2004) A ring-closing metathesis based synthesis of bicyclic nucleosides locked in S-type conformations by hydroxyl functionalised 3\u2032-4\u2032-trans linkages. Tetrahedron 60:3775\u20133786. \n https:\/\/doi.org\/10.1016\/j.tet.2004.03.019","journal-title":"Tetrahedron"},{"key":"31_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1021\/ar980051p","volume":"32","author":"J Wengel","year":"1999","unstructured":"Wengel J (1999) Synthesis of 3\u2032-C- and 4\u2032-C- branched oligodeoxynucleotides and the development of locked nucleic acid (LNA). Acc Chem Res 32:301\u2013310. \n https:\/\/doi.org\/10.1021\/ar980051p","journal-title":"Acc Chem Res"},{"key":"31_CR26","doi-asserted-by":"publisher","first-page":"10035","DOI":"10.1021\/jo9814445","volume":"63","author":"S Singh","year":"1998","unstructured":"Singh S, Kumar R, Wengel J (1998) Synthesis of 2\u2032-amino-LNA: a novel conformationally restricted high-affinity oligonucleotide analogue with a handle. J Org Chem 63:10035\u201310039. \n https:\/\/doi.org\/10.1021\/jo9814445","journal-title":"J Org Chem"},{"key":"31_CR27","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1046\/j.1432-1033.2003.03555.x","volume":"270","author":"J Kurreck","year":"2003","unstructured":"Kurreck J (2003) Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem 270:1628\u20131644. \n https:\/\/doi.org\/10.1046\/j.1432-1033.2003.03555.x","journal-title":"Eur J Biochem"},{"key":"31_CR28","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.tibtech.2004.06.004","volume":"22","author":"Z Paroo","year":"2004","unstructured":"Paroo Z, Corey D (2004) Challenges in RNAi in vivo. Trends Biotechnol 22:390\u2013394","journal-title":"Trends Biotechnol"},{"key":"31_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cbpa.2004.10.007","volume":"8","author":"M Manoharan","year":"2004","unstructured":"Manoharan M (2004) RNA interference and chemically modified small interfering RNAs. Curr Opin Chem Biol 8:570\u2013579. \n https:\/\/doi.org\/10.1016\/j.cbpa.2004.10.007","journal-title":"Curr Opin Chem Biol"},{"key":"31_CR30","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1021\/ja973535+","volume":"120","author":"VE Marquez","year":"1998","unstructured":"Marquez VE, Ezzitouni A, Russ P, Siddiqui MA, Ford H, Feldman RJ, Mitsuya H, George C, Barchi JJ (1998) HIV-1 reverse transcriptase can discriminate between two conformationally locked carbocyclic AZT triphosphate analogues. J Am Chem Soc 120:2780\u20132789. \n https:\/\/doi.org\/10.1021\/ja973535+","journal-title":"J Am Chem Soc"},{"key":"31_CR31","doi-asserted-by":"publisher","unstructured":"Herdewijn P (1996) Targeting RNA with conformationally restricted oligonucleotides. Liebigs Ann Chem 1337\u20131348. \n https:\/\/doi.org\/10.1002\/jlac.199619960902","DOI":"10.1002\/jlac.199619960902"},{"key":"31_CR32","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1021\/cr9603791","volume":"97","author":"ET Kool","year":"1997","unstructured":"Kool ET (1997) Preorganization of DNA: design principles for improving nucleic acid recognition by synthetic oligonucleotides. Chem Rev 97:1473\u20131488. \n https:\/\/doi.org\/10.1021\/cr9603791","journal-title":"Chem Rev"},{"key":"31_CR33","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.2174\/138955712803832681","volume":"12","author":"RG Soengas","year":"2012","unstructured":"Soengas RG, Silva S (2012) Spirocyclic nucleosides in medicinal chemistry: an overview. Mini Rev Med Chem 12:1485\u20131496. \n https:\/\/doi.org\/10.2174\/138955712803832681","journal-title":"Mini Rev Med Chem"},{"key":"31_CR34","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1021\/jo952218n","volume":"61","author":"T Gimisis","year":"1996","unstructured":"Gimisis T, Chatgilialoglu C (1996) 1,5-radical translocation protocol for the generation of C-1\u2032 radicals in nucleosides. Synthesis of spiro nucleosides through a rare 5-endo-trig cyclization. J Org Chem 61:1908\u20131909. \n https:\/\/doi.org\/10.1021\/jo952218n","journal-title":"J Org Chem"},{"key":"31_CR35","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1002\/(SICI)1521-3765(19991001)5:10<2866::AID-CHEM2866>3.0.CO;2-6","volume":"5","author":"C Chatgilialoglu","year":"1999","unstructured":"Chatgilialoglu C, Gimisis T, Spada GP (1999) C-1\u2032 radical-based approaches for the synthesis of anomeric spironucleosides. Chem Eur J 5:2866\u20132877. \n https:\/\/doi.org\/10.1002\/(SICI)1521-3765(19991001)5:10<2866::AID-CHEM2866>3.0.CO;2-6","journal-title":"Chem Eur J"},{"key":"31_CR36","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1021\/jo990611d","volume":"64","author":"A Kittaka","year":"1999","unstructured":"Kittaka A, Asakura T, Kuze T, Tanaka H, Yamada N, Nakamura KT, Miyasaka T (1999) Cyclization reactions of nucleoside anomeric radical with olefin tethered on base: factors that induce anomeric stereochemistry. J Org Chem 64:7081\u20137093. \n https:\/\/doi.org\/10.1021\/jo990611d","journal-title":"J Org Chem"},{"key":"31_CR37","doi-asserted-by":"publisher","unstructured":"Gimisis T, Castellari C, Chatglilialoglu C (1997) A new class of anomeric spironucleosides. Chem Commun 2089\u20132090. \n https:\/\/doi.org\/10.1039\/A705742C","DOI":"10.1039\/A705742C"},{"key":"31_CR38","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/0006-2952(96)00213-4","volume":"51","author":"MH Kouni El","year":"1996","unstructured":"El Kouni MH, Naguib FN, Panzica RP, Otter BA, Chu SH, Gosselin G, Chu CK, Schinazi RF, Shealy YF, Goudgaon N, Ozerov AA, Ueda T, Iltzsch MH (1996) Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii. Biochem Pharmacol 51:1687\u20131700. \n https:\/\/doi.org\/10.1016\/0006-2952(96)00213-4","journal-title":"Biochem Pharmacol"},{"key":"31_CR39","unstructured":"Sankyo (1987) Europe Patent Appl 0,232,572,A2. see CA 107: 149218n"},{"key":"31_CR40","unstructured":"Sankyo (1988) US Patent 4,952,234,A28. see CA 115: 66804q"},{"key":"31_CR41","unstructured":"Ciba-Geigy AG (1990) DE Patent 4,129,616 A1"},{"key":"31_CR42","unstructured":"Mitsubishi Kasei Corp (1990) Jap Patent 04\/222,589 A"},{"key":"31_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7164\/antibiotics.44.293","volume":"44","author":"M Nakajima","year":"1991","unstructured":"Nakajima M, Itoi K, Takamatsu Y, Kinoshita T, Okazaki T, Kawakubo K, Shindo M, Honma T, Tohjigamori M, Haneishi T (1991) Hydantocidin: a new compound with herbicidal activity from Streptomyces hygroscopicus. J Antibiot 44:293\u2013300. \n https:\/\/doi.org\/10.7164\/antibiotics.44.293","journal-title":"J Antibiot"},{"key":"31_CR44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1006\/pest.1995.1061","volume":"53","author":"DR Heim","year":"1995","unstructured":"Heim DR, Cseke C, Gerwick BC, Murdoch MG, Green SB (1995) Hydantocidin: a possible proherbicide inhibiting purine biosynthesis at the site of adenylosuccinate synthetase. Pestic Biochem Physiol 53:138\u2013145. \n https:\/\/doi.org\/10.1006\/pest.1995.1061","journal-title":"Pestic Biochem Physiol"},{"key":"31_CR45","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/0959-440X(95)80007-7","volume":"5","author":"JL Smith","year":"1995","unstructured":"Smith JL (1995) Enzymes of nucleotide synthesis. Curr Opin Struct Biol 5:752\u2013757","journal-title":"Curr Opin Struct Biol"},{"key":"31_CR46","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/pro.5560070409","volume":"7","author":"M Gregoriou","year":"1998","unstructured":"Gregoriou M, Noble ME, Watson KA, Garman EF, Krulle TM, de la Fuente C, Fleet GW, Oikonomakos NG, Johnson LN (1998) The structure of a glycogen phosphorylase glucopyranose spirohydantoin complex at 1.8 A resolution and 100\u00a0K: the role of the water structure and its contribution to binding. Protein Sci 7:915\u2013927. \n https:\/\/doi.org\/10.1002\/pro.5560070409","journal-title":"Protein Sci"},{"key":"31_CR47","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/340609a0","volume":"340","author":"D Barford","year":"1989","unstructured":"Barford D, Johnson LN (1989) The allosteric transition of glycogen phosphorylase. Nature 340:609\u2013616. \n https:\/\/doi.org\/10.1038\/340609a0","journal-title":"Nature"},{"key":"31_CR48","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S0959-440X(96)80005-4","volume":"6","author":"LN Johnson","year":"1996","unstructured":"Johnson LN, O\u2019Reilly M (1996) Control by phosphorylation. Curr Opin Struct Biol 6:762\u2013769. \n https:\/\/doi.org\/10.1016\/S0959-440X(96)80005-4","journal-title":"Curr Opin Struct Biol"},{"key":"31_CR49","doi-asserted-by":"publisher","first-page":"E133","DOI":"10.1152\/ajpendo.1997.272.1.E133","volume":"272","author":"HK Ortmeyer","year":"1997","unstructured":"Ortmeyer HK, Bodkin NL, Hansen BC (1997) Insulin regulates liver glycogen synthase and glycogen phosphorylase activity reciprocally in rhesus monkeys. Am J Phys 272:E133\u2013E138. \n https:\/\/doi.org\/10.1152\/ajpendo.1997.272.1.E133","journal-title":"Am J Phys"},{"key":"31_CR50","doi-asserted-by":"publisher","first-page":"10101","DOI":"10.1021\/bi00106a006","volume":"30","author":"JL Martin","year":"1991","unstructured":"Martin JL, Veluraja K, Ross K, Johnson LN, Fleet GWJ, Ramsden NG, Bruce I, Orchard MG, Oikonomakos NG, Papageorgiou AC, Leonidas DD, Tsitoura HS (1991) Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes. Biochemistry 30:10101\u201310116. \n https:\/\/doi.org\/10.1021\/bi00106a006","journal-title":"Biochemistry"},{"key":"31_CR51","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1021\/bi00185a011","volume":"33","author":"KA Watson","year":"1994","unstructured":"Watson KA, Mitchell EP, Johnson LN, Son JC, Bichard CJF, Orchard MG, Fleet GWJ, Oikonomakos NG, Leonidas DD, Kontou M, Papageorgiou AC (1994) Design of inhibitors of glycogen phosphorylase: a study of \u03b1- and \u03b2-C-glucosides and 1-thio- \u03b2-D-glucose compounds. Biochemistry 33:5745\u20135758. \n https:\/\/doi.org\/10.1021\/bi00185a011","journal-title":"Biochemistry"},{"key":"31_CR52","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1042\/bj3110845","volume":"311","author":"M Board","year":"1995","unstructured":"Board M, Bollen M, Stalmans W, Kim Y, Fleet GWJ, Johnson LN (1995) Effects of C-1 substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes. Biochem J 311:845\u2013852. \n https:\/\/doi.org\/10.1042\/bj3110845","journal-title":"Biochem J"},{"key":"31_CR53","doi-asserted-by":"publisher","first-page":"10745","DOI":"10.1021\/bi00500a005","volume":"29","author":"JL Martin","year":"1990","unstructured":"Martin JL, Johnson LN, Withers SG (1990) Comparison of the binding of glucose and glucose 1-phosphate derivatives to T-state glycogen phosphorylase b. Biochemistry 29:10745\u201310757. \n https:\/\/doi.org\/10.1021\/bi00500a005","journal-title":"Biochemistry"},{"key":"31_CR54","volume-title":"Diabetes, clinical science in practice","author":"K Osei","year":"1995","unstructured":"Osei K (1995) In: Leslie RDG, Robbins DC (eds) Diabetes, clinical science in practice. Cambridge University, Cambridge"},{"key":"31_CR55","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2337\/diab.37.6.667","volume":"37","author":"RA DeFronzo","year":"1988","unstructured":"DeFronzo RA (1988) Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667\u2013687","journal-title":"Diabetes"},{"key":"31_CR56","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/S0040-4020(01)96122-8","volume":"47","author":"S Mio","year":"1991","unstructured":"Mio S, Ichinose R, Goto K, Sugai S (1991) Synthetic studies on (+)-hydantocidin: a total synthesis of (+)-hydantocidin, a new herbicidal metabolite from microorganism. Tetrahedron 47:2111\u20132120. \n https:\/\/doi.org\/10.1016\/S0040-4020(01)96122-8","journal-title":"Tetrahedron"},{"key":"31_CR57","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3390\/molecules22112028","volume":"22","author":"RG Soengas","year":"2017","unstructured":"Soengas RG, da Silva G, Est\u00e9vez JC (2017) Synthesis of spironucleosides: past and future perspectives. Molecules 22:2028\u20132063. \n https:\/\/doi.org\/10.3390\/molecules22112028","journal-title":"Molecules"},{"key":"31_CR58","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0008-6215(02)00217-3","volume":"337","author":"M Shiozaki","year":"2002","unstructured":"Shiozaki M (2002) Syntheses of hydantocidin and C-2-thioxohydantocidin. Carbohydr Res 337:2077\u20132088. \n https:\/\/doi.org\/10.1016\/S0008-6215(02)00217-3","journal-title":"Carbohydr Res"},{"key":"31_CR59","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/S0040-4020(01)96123-X","volume":"47","author":"S Mio","year":"1991","unstructured":"Mio S, Shiraishi M, Sugai S (1991) Synthetic studies on (+)-hydantocidin (2): aldol addition approaches towards the stereoisomers of (+)-hydantocidin. Tetrahedron 47:2121\u20132132. \n https:\/\/doi.org\/10.1016\/S0040-4020(01)96123-X","journal-title":"Tetrahedron"},{"key":"31_CR60","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/S0040-4020(01)96125-3","volume":"47","author":"S Mio","year":"1991","unstructured":"Mio S, Ueda M, Hamura M, Kitakawa J, Sugai S (1991) Synthetic studies on (+)-hydantocidin (4): synthesis of stereoisomers of (+)-hydantocidin. Tetrahedron 47:2145\u20132154. \n https:\/\/doi.org\/10.1016\/S0040-4020(01)96125-3","journal-title":"Tetrahedron"},{"key":"31_CR61","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/00021369.1991.10870692","volume":"55","author":"S Mio","year":"1991","unstructured":"Mio S, Sano H, Shindou M, Honma T, Sugai S (1991) Synthesis and herbicidal activity of deoxy derivatives of (+)-hydantocidin. Agric Biol Chem 55:1105\u20131109. \n https:\/\/doi.org\/10.1080\/00021369.1991.10870692","journal-title":"Agric Biol Chem"},{"key":"31_CR62","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/S0040-4039(00)61745-8","volume":"34","author":"JW Burton","year":"1993","unstructured":"Burton JW, Son JC, Fairbanks AJ, Choi SS, Taylor H, Watkin DJ, Winchester BG, Fleet GWJ (1993) Anomeric spirohydantoins of mannofuranose: approaches to novel anomeric amino acids by oxidative ring contraction. Tetrahedron Lett 34:6119\u20136122. \n https:\/\/doi.org\/10.1016\/S0040-4039(00)61745-8","journal-title":"Tetrahedron Lett"},{"key":"31_CR63","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/0040-4039(95)00198-L","volume":"36","author":"TW Brandstetter","year":"1995","unstructured":"Brandstetter TW, Kim Y, Son JC, Taylor HM, Lilley PMDQ, Watkin DJ, Johnson LN, Oikonomakos NG, Fleet GWJ (1995) Spirohydantoins of glucofuranose: analogues of hydantocidin. Tetrahedron Lett 36:2149\u20132152. \n https:\/\/doi.org\/10.1016\/0040-4039(95)00198-L","journal-title":"Tetrahedron Lett"},{"key":"31_CR64","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0957-4166(95)00432-7","volume":"7","author":"TW Brandstetter","year":"1996","unstructured":"Brandstetter TW, Wormald MR, Dwek RA, Butters TD, Platt FM, Tsitsanou KE, Zographos SE, Oikonomakos NG, Fleet GWJ (1996) A galactopyranose analogue of hydantocidin. Tetrahedron Asymmetry 7:157\u2013170. \n https:\/\/doi.org\/10.1016\/0957-4166(95)00432-7","journal-title":"Tetrahedron Asymmetry"},{"key":"31_CR65","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0957-4166(96)00014-6","volume":"7","author":"JC Est\u00e9vez","year":"1996","unstructured":"Est\u00e9vez JC, Smith MD, Wormald MR, Besra GS, Brenan PJ, Nash RJ, Fleet GWJ (1996) Mimics of L-rhamnose: analogues of rhamnopyranose containing a constituent amino acid at the anomeric position. A rhamnopyranose analogue of hydantocidin. Tetrahedron Asymmetry 7:391\u2013394. \n https:\/\/doi.org\/10.1016\/0957-4166(96)00014-6","journal-title":"Tetrahedron Asymmetry"},{"key":"31_CR66","doi-asserted-by":"publisher","unstructured":"Fuente C, Kr\u00fclle TM, Watson KA, Gregoriou M, Johnson LN, Zographos SE, Oikonomakos NG, Fleet GWJ (1997) Glucopyranose analogues of spirohydantoins: specific inhibitors of glycogen phosphorylase. Synlett 485\u2013487. \n https:\/\/doi.org\/10.1055\/s-1997-940277","DOI":"10.1055\/s-1997-940277"},{"key":"31_CR67","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/0040-4039(95)00197-K","volume":"36","author":"CJF Bichard","year":"1995","unstructured":"Bichard CJF, Mitchell EP, Wormald MR, Watson KA, Johnson LN, Zographos S, Koutra DD, Oikonomakos NG, Fleet GWJ (1995) Potent inhibition of glycogen phosphorylase by a spirohydantoin of glucopyranose: first pyranose analogues of hydantocidin. Tetrahedron Lett 36:2145\u20132148. \n https:\/\/doi.org\/10.1016\/0040-4039(95)00197-K","journal-title":"Tetrahedron Lett"},{"key":"31_CR68","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.tetasy.2006.07.027","volume":"17","author":"Y Bl\u00e9riot","year":"2006","unstructured":"Bl\u00e9riot Y, Simone MI, Wormald MR, Dwek RA, Watkin DJ, Fleet GWJ (2006) Sugar amino acids at the anomeric position of carbohydrates: synthesis of spirocyclic amino acids of 6-deoxy-L-lyxofuranose. Tetrahedron Asymmetry 17:2276\u20132286. \n https:\/\/doi.org\/10.1016\/j.tetasy.2006.07.027","journal-title":"Tetrahedron Asymmetry"},{"key":"31_CR69","doi-asserted-by":"publisher","first-page":"7953","DOI":"10.1016\/S0040-4039(00)61521-6","volume":"34","author":"JC Est\u00e9vez","year":"1993","unstructured":"Est\u00e9vez JC, Smith MD, Lane AL, Crook S, Watkin DJ, Besra GS, Brennan PJ, Nash RJ, Fleet GWJ (1993) Synthesis of cyclopentane spirohydantoins by aldol cyclisations: an approach to highly substituted \u03b1-cyclopentane amino acids. Tetrahedron Lett 34:7953\u20137956. \n https:\/\/doi.org\/10.1016\/S0040-4039(00)61521-6","journal-title":"Tetrahedron Lett"},{"key":"31_CR70","doi-asserted-by":"publisher","first-page":"6369","DOI":"10.1021\/jo050827h","volume":"70","author":"TQ Pham","year":"2005","unstructured":"Pham TQ, Pyne SG, Skelton BW, White AH (2005) Synthesis of carbocyclic hydantocidins via regioselective and diastereoselective phosphine catalyzed [3\u00a0+\u00a02]-cycloadditions to 5-methylenehydantoins. J Org Chem 70:6369\u20136377. \n https:\/\/doi.org\/10.1021\/jo050827h","journal-title":"J Org Chem"},{"key":"31_CR71","doi-asserted-by":"publisher","first-page":"6669","DOI":"10.1016\/0040-4020(95)00324-2","volume":"51","author":"S Hanessian","year":"1995","unstructured":"Hanessian S, Sanc\u00e9au JY, Chemla P (1995) Synthesis of surrogate structures related to the herbicidal agent hydantocidin. Tetrahedron 51:6669\u20136678. \n https:\/\/doi.org\/10.1016\/0040-4020(95)00324-2","journal-title":"Tetrahedron"},{"key":"31_CR72","doi-asserted-by":"publisher","first-page":"12561","DOI":"10.1016\/0040-4020(95)00810-U","volume":"51","author":"H Sano","year":"1995","unstructured":"Sano H, Mio S, Kitagawa J, Shindou M, Honma T, Sugai S (1995) Synthesis of spirothiohydantoin analogues of hydantocidin. Tetrahedron 51:12561\u201312572. \n https:\/\/doi.org\/10.1016\/0040-4020(95)00810-U","journal-title":"Tetrahedron"},{"key":"31_CR73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1752-153X-5-7","volume":"5","author":"AA Ghoneim","year":"2011","unstructured":"Ghoneim AA (2011) Synthesis of some nucleosides derivatives from L-rhamnose with expected biological activity. Chem Cent J 5:7. \n https:\/\/doi.org\/10.1186\/1752-153X-5-7","journal-title":"Chem Cent J"},{"key":"31_CR74","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1016\/S0040-4020(97)00213-5","volume":"53","author":"E \u0150sz","year":"1997","unstructured":"\u0150sz E, Soms\u00e1k L, Szil\u00e1gyi L, Dinya Z (1997) A straightforward route to hydantocidin analogues with pyranose ring structure. Tetrahedron 53:5813\u20135824. \n https:\/\/doi.org\/10.1016\/S0040-4020(97)00213-5","journal-title":"Tetrahedron"},{"key":"31_CR75","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S0960-894X(99)00192-4","volume":"9","author":"E \u0150sz","year":"1999","unstructured":"\u0150sz E, Soms\u00e1k L, Szil\u00e1gyi L, Kov\u00e1cs L, Docsa T, T\u00f3th B, Gergely P (1999) Efficient inhibition of muscle and liver glycogen phosphorylases by a new glucopyranosylidene-spiro-thiohydantoin. Bioorg Med Chem Lett 9:1385\u20131390. \n https:\/\/doi.org\/10.1016\/S0960-894X(99)00192-4","journal-title":"Bioorg Med Chem Lett"},{"key":"31_CR76","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0957-4166(99)00486-3","volume":"11","author":"L Soms\u00e1k","year":"2000","unstructured":"Soms\u00e1k L, Nagy V, Docsa T, T\u00f3th B, Gergely P (2000) Gram-scale synthesis of a glucopyranosylidene-spirothiohydantoin and its effect on hepatic glycogen metabolism studied in vitro and in vivo. Tetrahedron Asymmetry 11:405\u2013408. \n https:\/\/doi.org\/10.1016\/S0957-4166(99)00486-3","journal-title":"Tetrahedron Asymmetry"},{"key":"31_CR77","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/S0957-4166(00)00107-5","volume":"11","author":"L Soms\u00e1k","year":"2000","unstructured":"Soms\u00e1k L, Nagy V (2000) A new, scalable preparation of a glucopyranosylidene-spiro-thiohydantoin: one of the best inhibitors of glycogen phosphorylases. Tetrahedron Asymmetry 11:1719\u20131727. \n https:\/\/doi.org\/10.1016\/S0957-4166(00)00107-5","journal-title":"Tetrahedron Asymmetry"},{"key":"31_CR78","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1021\/jm010892t","volume":"44","author":"L Soms\u00e1k","year":"2001","unstructured":"Soms\u00e1k L, Kov\u00e1cs L, T\u00f3th M, \u0150sz E, Szil\u00e1gyi L, Gy\u00f6rgyde\u00e1k Z, Dinya Z, Docsa T, T\u00f3th B, Gergely P (2001) Synthesis of and a comparative study on the inhibition of muscle and liver glycogen phosphorylases by epimeric pairs of D-gluco- and D-xylopyranosylidene-spiro-(thio)hydantoins and N-(D-glucopyranosyl) amides. J Med Chem 44:2843\u20132848. \n https:\/\/doi.org\/10.1021\/jm010892t","journal-title":"J Med Chem"},{"key":"31_CR79","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.carres.2005.03.003","volume":"340","author":"L Kandra","year":"2005","unstructured":"Kandra L, Remenyik J, Batta G, Soms\u00e1k L, Gy\u00e9m\u00e1nt G, Park KH (2005) Enzymatic synthesis of a new inhibitor of \u03b1-amylases: acarviosinyl-isomaltosyl-spiro-thiohydantoin. Carbohydr Res 340:1311\u20131317. \n https:\/\/doi.org\/10.1016\/j.carres.2005.03.003","journal-title":"Carbohydr Res"},{"key":"31_CR80","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0065-2318(08)60181-X","volume":"49","author":"L Soms\u00e1k","year":"1991","unstructured":"Soms\u00e1k L, Ferrier RJ (1991) Radical-mediated brominations at ring positions of carbohydrates. Adv Carbohydr Chem Biochem 49:37\u201392. \n https:\/\/doi.org\/10.1016\/S0065-2318(08)60181-X","journal-title":"Adv Carbohydr Chem Biochem"},{"key":"31_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1039\/9781849737173-00001","volume":"39","author":"L Soms\u00e1k","year":"2013","unstructured":"Soms\u00e1k L, Czifr\u00e1k K (2013) Radical-mediated brominations at ring-positions of carbohydrates \u2013 35\u00a0years later. Carbohydr Chem 39:1\u201337. \n https:\/\/doi.org\/10.1039\/9781849737173-00001","journal-title":"Carbohydr Chem"},{"key":"31_CR82","doi-asserted-by":"publisher","unstructured":"Maza S, L\u00f3pez O, Martos S, Maya I, Fern\u00e1ndez-Bola\u00f1os JG (2009) Synthesis of the first selenium-containing acyclic nucleosides and anomeric spironucleosides from carbohydrate precursors. Eur J Org Chem 5239\u20135246. \n https:\/\/doi.org\/10.1002\/ejoc.200900793","DOI":"10.1002\/ejoc.200900793"},{"key":"31_CR83","doi-asserted-by":"publisher","first-page":"8889","DOI":"10.1016\/S0040-4039(00)78526-1","volume":"35","author":"JC Estevez","year":"1994","unstructured":"Estevez JC, Ardron H, Wormald MR, Brown D, Fleet GWJ (1994) Spirocyclic peptides at the anomeric position of mannofuranose. Tetrahedron Lett 35:8889\u20138890. \n https:\/\/doi.org\/10.1016\/S0040-4039(00)78526-1","journal-title":"Tetrahedron Lett"},{"key":"31_CR84","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/S0957-4166(98)00206-7","volume":"9","author":"JC Estevez","year":"1998","unstructured":"Estevez JC, Burton JW, Est\u00e9vez RE, Ardron H, Wormald MR, Dwek RA, Brown D, Fleet GWJ (1998) Spirodiketopiperazines of mannofuranose: carbopeptoid \u03b1-amino acid esters at the anomeric position of mannofuranose. Tetrahedron Asymmetry 9:2137\u20132154. \n https:\/\/doi.org\/10.1016\/S0957-4166(98)00206-7","journal-title":"Tetrahedron Asymmetry"},{"key":"31_CR85","doi-asserted-by":"publisher","first-page":"8287","DOI":"10.1016\/0040-4039(95)01732-W","volume":"36","author":"JC Estevez","year":"1995","unstructured":"Estevez JC, Long DD, Wormald MR, Dwek RA, Fleet GWJ (1995) Spirodiketopiperazines at the anomeric position of mannopyranose: novel N-linked glycopeptides incorporating an \u03b1-amino acid at the anomeric position of mannopyranose. Tetrahedron Lett 36:8287\u20138290. \n https:\/\/doi.org\/10.1016\/0040-4039(95)01732-W","journal-title":"Tetrahedron Lett"},{"key":"31_CR86","doi-asserted-by":"publisher","first-page":"8291","DOI":"10.1016\/0040-4039(95)01733-X","volume":"36","author":"TM Kr\u00fclle","year":"1995","unstructured":"Kr\u00fclle TM, Watson KA, Gregoriou M, Johnson LN, Crook S, Watkin DJ, Griffith RC, Nash RJ, Tsitsanou KE, Zographos SE, Oikonomakos NG, Fleet GWJ (1995) Specific inhibition of glycogen phosphorylase by a spirodiketopiperazine at the anomeric position of glucopyranose. Tetrahedron Lett 36:8291\u20138294. \n https:\/\/doi.org\/10.1016\/0040-4039(95)01733-X","journal-title":"Tetrahedron Lett"},{"key":"31_CR87","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0957-4166(96)00013-4","volume":"7","author":"JC Estevez","year":"1996","unstructured":"Estevez JC, Smith MD, Lane AL, Crook S, Watkin DJ, Besra GS, Brennan PJ, Nash RJ, Fleet GWJ (1996) Mimics of L-rhamnose: anomeric spirohydantoins and diketopiperazines \u2013 approaches to novel N-linked glycopeptides of rhamnofuranose. Tetrahedron Asymmetry 7:387\u2013390. \n https:\/\/doi.org\/10.1016\/0957-4166(96)00013-4","journal-title":"Tetrahedron Asymmetry"},{"key":"31_CR88","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1039\/B009940F","volume":"1","author":"DD Long","year":"2001","unstructured":"Long DD, Tennant-Eyles RJ, Est\u00e9vez JC, Wormald MR, Dwek RA, Smith MD, Fleet GWJ et al (2001) Carbopeptoids: peptides and diketopiperazines incorporating the anomeric centre of mannopyranose. J Chem Soc Perkin Trans 1:807\u2013813. \n https:\/\/doi.org\/10.1039\/B009940F","journal-title":"J Chem Soc Perkin Trans"},{"key":"31_CR89","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/218069a0","volume":"218","author":"Y Kyogoku","year":"1968","unstructured":"Kyogoku Y, Lord RC, Rich A (1968) Specific hydrogen bonding of barbiturates to adenine derivatives. Nature 218:69\u201372. \n https:\/\/doi.org\/10.1038\/218069a0","journal-title":"Nature"},{"key":"31_CR90","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0024-3205(96)00199-3","volume":"59","author":"T Ito","year":"1996","unstructured":"Ito T, Suzuki T, Wellman SE, Ho IK (1996) Pharmacology of barbiturate tolerance\/dependence: GABAA receptors and molecular aspects. Life Sci 59:169\u2013195. \n https:\/\/doi.org\/10.1016\/0024-3205(96)00199-3","journal-title":"Life Sci"},{"key":"31_CR91","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1021\/jo016194y","volume":"67","author":"A Renard","year":"2002","unstructured":"Renard A, Lhomme J, Kotera M (2002) Synthesis and properties of spiro nucleosides containing the barbituric acid moiety. J Org Chem 67:1302\u20131307. \n https:\/\/doi.org\/10.1021\/jo016194y","journal-title":"J Org Chem"},{"key":"31_CR92","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0008-6215(99)00039-7","volume":"316","author":"J Andersch","year":"1999","unstructured":"Andersch J, Sicker D, Wilde H (1999) Methyl D-arabino-hex-2-ulopyranosonate as a building block for spiro[1,4,-benzoxazine-2,2\u2032-pyrans]. Carbohydr Res 316:85\u201394. \n https:\/\/doi.org\/10.1016\/S0008-6215(99)00039-7","journal-title":"Carbohydr Res"},{"key":"31_CR93","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/jhet.5570360220","volume":"36","author":"J Andersch","year":"1999","unstructured":"Andersch J, Sicker D, Wilde H (1999) Synthesis of spiro 1,4-benzothiazine-2,2\u2032-pyrans starting from methyl \u03b2-D-arabino-2-hexulopyranosonate. J Heterocyclic Chem 36:457\u2013460. \n https:\/\/doi.org\/10.1002\/jhet.5570360220","journal-title":"J Heterocyclic Chem"},{"key":"31_CR94","first-page":"436","volume":"12","author":"L Soms\u00e1k","year":"1986","unstructured":"Soms\u00e1k L, Batta G, Farkas I, Park\u00e1nyi L, K\u00e1lm\u00e1n A, Somogyi \u00c1 (1986) Synthesis and stereochemistry of a new spiro glycosylidene heterocycle from the reaction of 1-bromoglycosyl cyanides with S-nucleophiles: complete identification of hydrogen bridges by N.M.R. Methods and X-ray analysis. J Chem Res 12:436\u2013437","journal-title":"J Chem Res"},{"key":"31_CR95","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/S0040-4020(99)00034-4","volume":"55","author":"E \u0150sz","year":"1999","unstructured":"\u0150sz E, Szil\u00e1gyi L, Soms\u00e1k L, B\u00e9nyei A (1999) Synthesis of novel glycosylidene-spiro-heterocycles related to hydantocidin. Tetrahedron 55:2419\u20132430. \n https:\/\/doi.org\/10.1016\/S0040-4020(99)00034-4","journal-title":"Tetrahedron"},{"key":"31_CR96","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.1021\/jo049184g","volume":"69","author":"A Meijer","year":"2004","unstructured":"Meijer A, Ellervik U (2004) Interhalogens (ICI\/IBr3) and AgOTf in thioglycoside activation; synthesis of bislactam analogues of ganglioside GD3. J Org Chem 69:6249\u20136256. \n https:\/\/doi.org\/10.1021\/jo049184g","journal-title":"J Org Chem"},{"key":"31_CR97","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/s0008-6215(02)00036-8","volume":"337","author":"N Hossain","year":"2002","unstructured":"Hossain N, Zapata A, Wilstermann M, Nilsson UJ, Magnusson G (2002) Synthesis of GD3-lactam: a potential ligand for the development of an anti-melanoma vaccine. Carbohydr Res 337:569\u2013580. \n https:\/\/doi.org\/10.1016\/s0008-6215(02)00036-8","journal-title":"Carbohydr Res"},{"key":"31_CR98","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/00397919608003864","volume":"26","author":"C Lamberth","year":"1996","unstructured":"Lamberth C, Blarer S (1996) Concise approach to 1-thia-hydantocidin. Synth Commun 26:75\u201381. \n https:\/\/doi.org\/10.1080\/00397919608003864","journal-title":"Synth Commun"},{"key":"31_CR99","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/S0957-4166(01)00223-3","volume":"12","author":"C Gasch","year":"2001","unstructured":"Gasch C, Pradera MA, Salameh BAB, Molina JL, Fuentes J (2001) Isothiocyanato derivatives of sugars in the stereoselective synthesis of spironucleosides and spiro-C-glycosides. Tetrahedron Asymmetry 12:1267\u20131277. \n https:\/\/doi.org\/10.1016\/S0957-4166(01)00223-3","journal-title":"Tetrahedron Asymmetry"},{"key":"31_CR100","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tet.2005.09.128","volume":"62","author":"C Gash","year":"2006","unstructured":"Gash C, Pradera MA, Salameh BAB, Molina JL, Fuentes J (2006) Stereocontrolled synthesis of thiohydantoin spiro-nucleosides from sugar spiroacetals. Tetrahedron 62:97\u2013111. \n https:\/\/doi.org\/10.1016\/j.tet.2005.09.128","journal-title":"Tetrahedron"},{"key":"31_CR101","doi-asserted-by":"publisher","unstructured":"Silva S, S\u00e1nchez-Fern\u00e1ndez EM, Ortiz Mellet C, Tatibou\u00ebt A, Rauter AP, Rollin P (2013) N-Thiocarbonyl iminosugars: synthesis and evaluation of castanospermine analogues bearing oxazole-2(3H)-thione moieties. Eur J Org Chem 7941\u20137951. \n https:\/\/doi.org\/10.1002\/ejoc.201300720","DOI":"10.1002\/ejoc.201300720"},{"key":"31_CR102","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.3762\/bjoc.11.249","volume":"11","author":"M Vangala","year":"2015","unstructured":"Vangala M, Shinde GP (2015) Synthesis of D-fructose-derived spirocyclic 2-substituted-2-oxazoline ribosides. Beilstein J Org Chem 11:2289\u20132296. \n https:\/\/doi.org\/10.3762\/bjoc.11.249","journal-title":"Beilstein J Org Chem"},{"key":"31_CR103","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3762\/bjoc.12.18","volume":"12","author":"J Kraft","year":"2016","unstructured":"Kraft J, Golkowski M, Ziegler T (2016) Spiro-fused carbohydrate oxazoline ligands: synthesis and application as enantio-discrimination agents in asymmetric allylic alkylation. Beilstein J Org Chem 12:166\u2013171. \n https:\/\/doi.org\/10.3762\/bjoc.12.18","journal-title":"Beilstein J Org Chem"},{"key":"31_CR104","doi-asserted-by":"publisher","unstructured":"Soengas RG (2010) A straightforward route to novel \u03b1,\u03b1-disubstituted tetrahydrofuran \u03b2-amino acids and spirodiketopiperazines from sugar lactones. Synlett 2549\u20132552. \n https:\/\/doi.org\/10.1055\/s-0030-1258572","DOI":"10.1055\/s-0030-1258572"},{"key":"31_CR105","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.tet.2004.01.030","volume":"60","author":"C Taillefumier","year":"2004","unstructured":"Taillefumier C, Thielges S, Chapleur Y (2004) Anomeric spiroannelated 1,4-diazepine-2,5-diones from Furano exo-glycals: towards a new class of spironucleosides. Tetrahedron 60:2213\u20132224. \n https:\/\/doi.org\/10.1016\/j.tet.2004.01.030","journal-title":"Tetrahedron"},{"key":"31_CR106","doi-asserted-by":"publisher","first-page":"9911","DOI":"10.1016\/j.tet.2008.08.002","volume":"64","author":"X Li","year":"2008","unstructured":"Li X, Wang R, Wang Y, Chen H, Li Z, Ba C, Zhang J (2008) Stereoselective synthesis and biological activity of novel spirooxazinanone-C-glycosides. Tetrahedron 64:9911\u20139920. \n https:\/\/doi.org\/10.1016\/j.tet.2008.08.002","journal-title":"Tetrahedron"},{"key":"31_CR107","doi-asserted-by":"publisher","first-page":"9539","DOI":"10.1021\/jo801576k","volume":"73","author":"B Wang","year":"2008","unstructured":"Wang B, Wong OA, Zhao M-X, Shi Y (2008) Asymmetric epoxidation of 1,1-disubstituted terminal olefins by chiral dioxirane via a planar-like transition state. J Org Chem 73:9539\u20139543. \n https:\/\/doi.org\/10.1021\/jo801576k","journal-title":"J Org Chem"},{"key":"31_CR108","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1021\/jo900739q","volume":"74","author":"OA Wong","year":"2009","unstructured":"Wong OA, Wang B, Zhao M-X, Shi Y (2009) Asymmetric epoxidation catalyzed by \u03b1,\u03b1-dimethylmorpholinone ketone. Methyl group effect on spiro and planar transition states. J Org Chem 74:6335\u20136338. \n https:\/\/doi.org\/10.1021\/jo900739q","journal-title":"J Org Chem"},{"key":"31_CR109","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.carres.2005.02.021","volume":"340","author":"R Elek","year":"2005","unstructured":"Elek R, Kiss L, Praly JP, Soms\u00e1k L (2005) \u03b2-D-Galactopyranosyl-thiohydroximates and D-galactopyranosylidene-spiro-oxathiazoles: synthesis and enzymatic evaluation against E. coli D-galactosidase. Carbohydr Res 340:1397\u20131402. \n https:\/\/doi.org\/10.1016\/j.carres.2005.02.021","journal-title":"Carbohydr Res"},{"key":"31_CR110","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1016\/j.bmc.2009.05.080","volume":"17","author":"V Nagy","year":"2009","unstructured":"Nagy V, Benltifa M, Vidal S, Berzs\u00e9nyi E, Teilhet C, Czifr\u00e1k K, Batta G, Docsa T, Gergely P, Soms\u00e1k L, Praly JP (2009) Glucose-based spiro-heterocycles as potent inhibitors of glycogen phosphorylase. Bioorg Med Chem 17:5696\u20135707. \n https:\/\/doi.org\/10.1016\/j.bmc.2009.05.080","journal-title":"Bioorg Med Chem"},{"key":"31_CR111","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1016\/j.bmcl.2008.08.052","volume":"18","author":"L Soms\u00e1k","year":"2008","unstructured":"Soms\u00e1k L, Nagy V, Vidal S, Czifr\u00e1k K, Berzs\u00e9nyi E, Praly JP (2008) Novel design principle validated: glucopyranosylidene-spiro-oxathiazole as new nanomolar inhibitor of glycogen phosphorylase, potential antidiabetic agent. Bioorg Med Chem 18:5680\u20135683. \n https:\/\/doi.org\/10.1016\/j.bmcl.2008.08.052","journal-title":"Bioorg Med Chem"},{"key":"31_CR112","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/molecules22101760","volume":"22","author":"KE Szab\u00f3","year":"2017","unstructured":"Szab\u00f3 KE, Kun S, M\u00e1ndi A, Kurt\u00e1n T, Soms\u00e1k L (2017) Glucopyranosylidene-spiro-thiazolinones: synthetic studies and determination of absolute configuration by TDDFT-ECD calculations. Molecules 22:1760. \n https:\/\/doi.org\/10.3390\/molecules22101760","journal-title":"Molecules"},{"key":"31_CR113","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.carres.2011.07.001","volume":"346","author":"K Czifr\u00e1k","year":"2011","unstructured":"Czifr\u00e1k K, Gy\u00f3llai V, K\u00f6v\u00e9r KE, Soms\u00e1k L (2011) Ritter-type reaction of C-(1-bromo-1-deoxy-D-glycopyranosyl)formamides and its application for the synthesis of oligopeptides incorporating anomeric \u03b1-amino acids. Carbohydr Res 346:2104\u20132112. \n https:\/\/doi.org\/10.1016\/j.carres.2011.07.001","journal-title":"Carbohydr Res"},{"key":"31_CR114","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.carres.2014.05.020","volume":"399","author":"L Soms\u00e1k","year":"2014","unstructured":"Soms\u00e1k L, Bokor \u00c9, Czibere B, Czifr\u00e1k K, Kopp\u00e1ny C, Kulcs\u00e1r L, Kun S, Szil\u00e1gyi E, T\u00f3th M, Docsa T, Gergely P (2014) Synthesis of C-xylopyranosyl- and xylopyranosylidene-spiroheterocycles as potential inhibitors of glycogen phosphorylase. Carbohydr Res 399:38\u201348. \n https:\/\/doi.org\/10.1016\/j.carres.2014.05.020","journal-title":"Carbohydr Res"},{"key":"31_CR115","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.1016\/j.bmc.2009.08.060","volume":"17","author":"M Benltifa","year":"2009","unstructured":"Benltifa M, Hayes JM, Vidal S, Gueyrard D, Goekjian PG, Praly JP, Kizilis G, Tiraidis C, Alexacou K, Chrysina ED, Zographos SE, Leonidas DD, Archontis G, Oikonomakos NG (2009) Glucose-based spiro-isoxazolines: a new family of potent glycogen phosphorylase inhibitors. Bioorg Med Chem 17:7368\u20137380. \n https:\/\/doi.org\/10.1016\/j.bmc.2009.08.060","journal-title":"Bioorg Med Chem"},{"key":"31_CR116","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ejmech.2015.12.004","volume":"108","author":"D Goyard","year":"2016","unstructured":"Goyard D, K\u00f3nya B, Chajistamatiou AS, Chrysina ED, Leroy J, Balzarin S, Tournier M, Tousch D, Petit P, Duret C, Maurel P, Soms\u00e1k L, Docsa T, Gergely P, Praly JP, Azay-Milhau J, Vidal S (2016) Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition. Eur J Med Chem 108:444\u2013454. \n https:\/\/doi.org\/10.1016\/j.ejmech.2015.12.004","journal-title":"Eur J Med Chem"},{"key":"31_CR117","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1016\/j.bmc.2014.05.076","volume":"22","author":"K Czifr\u00e1k","year":"2014","unstructured":"Czifr\u00e1k K, P\u00e1hi A, De\u00e1k S, Kiss-Szikszai A, K\u00f6v\u00e9r KE, Docsa T, Gergely P, Alexacou KM, Papakonstantinou M, Leonidas DD, Zographos SE, Chrysina ED, Soms\u00e1k L (2014) Glucopyranosylidene-spiro-iminothiazolidinone, a new bicyclic ring system: synthesis, derivatization, and evaluation for inhibition of glycogen phosphorylase by enzyme kinetic and crystallographic methods. Bioorg Med Chem 22:4028\u20134041. \n https:\/\/doi.org\/10.1016\/j.bmc.2014.05.076","journal-title":"Bioorg Med Chem"},{"key":"31_CR118","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1016\/S0040-4039(99)00273-7","volume":"40","author":"C Chatgilialoglu","year":"1999","unstructured":"Chatgilialoglu C, Ferreri C, Gimisis T (1999) Anionically induced formation of anomeric spironucleosides from l\u2032-C-cyano-2\u2032-deoxyuridine. Tetrahedron Lett 40:2837\u20132840. \n https:\/\/doi.org\/10.1016\/S0040-4039(99)00273-7","journal-title":"Tetrahedron Lett"},{"key":"31_CR119","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1081\/NCN-200031391","volume":"23","author":"C Chatgilialoglu","year":"2004","unstructured":"Chatgilialoglu C, Ferreri C, Gimisis T, Roberti M, Balzarini J, de Clercq E (2004) Synthesis and biological evaluation of novel 1\u2032-branched and spironucleoside analogues. Nucleosides Nucleotides Nucleic Acids 23:1565\u20131581. \n https:\/\/doi.org\/10.1081\/NCN-200031391","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"31_CR120","doi-asserted-by":"publisher","first-page":"11685","DOI":"10.1002\/chem.201403560","volume":"20","author":"A Dell\u2019Isola","year":"2014","unstructured":"Dell\u2019Isola A, McLachlan MMW, Neuman BW, Al-Mullah HMN, Binks AWD, Elvidge W, Shankland K, Cobb JA (2014) Synthesis and antiviral properties of spirocyclic [1,2,3]-triazolooxazine nucleosides. Chem Eur J 20:11685\u201311689. \n https:\/\/doi.org\/10.1002\/chem.201403560","journal-title":"Chem Eur J"},{"key":"31_CR121","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1021\/ol100451p","volume":"13","author":"XG Tong","year":"2011","unstructured":"Tong XG, Zhou LL, Wang YH, Xia C, Wang Y, Liang M, Hou FF, Cheng YX (2011) Acortatarins A and B, two novel antioxidative spiroalkaloids with a naturally unusual morpholine motif from Acorus tatarinowii. Org Lett 13:1844\u20131847. \n https:\/\/doi.org\/10.1021\/ol100451p","journal-title":"Org Lett"},{"key":"31_CR122","doi-asserted-by":"publisher","unstructured":"Geng HM, Stubbing LA, Chen JL, Furkert DP, Brimble MA (2014) Synthesis of the revised structure of acortatarin A. Eur J Org Chem 6227\u20136241. \n https:\/\/doi.org\/10.1002\/ejoc.201403000","DOI":"10.1002\/ejoc.201403000"},{"key":"31_CR123","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1055\/s-0034-1380172","volume":"26","author":"Z Cao","year":"2015","unstructured":"Cao Z, Li Y, Wang S, Guo X, Wang L, Zhao W (2015) Total synthesis of two pyrrole spiroketal alkaloids: pollenopyrroside A and capparisine B. Synlett 26:921\u2013926. \n https:\/\/doi.org\/10.1055\/s-0034-1380172","journal-title":"Synlett"},{"key":"31_CR124","doi-asserted-by":"publisher","first-page":"8150","DOI":"10.1021\/jm101050a","volume":"53","author":"TH Jonckers","year":"2010","unstructured":"Jonckers TH, Lin TI, Buyck C, Lachau-Durand S, Vandyck K, van Hoof S, Vandekerckhove LA, Hu L, Berke JM, Vijgen L, Dillen LL, Cummings MD, de Kock H, Nilsson M, Sund C, Rydeg\u00e5rd C, Samuelsson B, Rosenquist A, Fanning G, van Emelen K, Simmen K, Raboisson P (2010) 2\u2032-Deoxy-2\u2032-spirocyclopropylcytidine revisited: a new and selective inhibitor of the hepatitis C virus NS5B polymerase. J Med Chem 53:8150\u20138160. \n https:\/\/doi.org\/10.1021\/jm101050a","journal-title":"J Med Chem"},{"key":"31_CR125","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/15257770.2012.695839","volume":"31","author":"GH Shen","year":"2012","unstructured":"Shen GH, Hong JH (2012) Synthesis of novel 2\u2032-spirocyclopropyl-5\u2032-deoxyphosphonic acid furanosyl nucleoside analogues as potent antiviral agents. Nucleosides Nucleotides Nucleic Acids 31:503\u2013521. \n https:\/\/doi.org\/10.1080\/15257770.2012.695839","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"31_CR126","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/anie.196804561","volume":"7","author":"J Gosselck","year":"1968","unstructured":"Gosselck J, Schmidt G (1968) A new route to 1,1-disubstituted cyclopropane. Angew Chem Int Ed 7:456\u2013457. \n https:\/\/doi.org\/10.1002\/anie.196804561","journal-title":"Angew Chem Int Ed"},{"key":"31_CR127","doi-asserted-by":"publisher","first-page":"868","DOI":"10.5012\/bkcs.2013.34.3.868","volume":"34","author":"GH Shen","year":"2013","unstructured":"Shen GH, Hong JH (2013) Synthesis of novel 2\u2032-spirocyclopropanoid 4\u2032-deoxythreosyl phosphonic acid nucleoside analogues. Bull Kor Chem Soc 34:868\u2013874. \n https:\/\/doi.org\/10.5012\/bkcs.2013.34.3.868","journal-title":"Bull Kor Chem Soc"},{"key":"31_CR128","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1039\/B306354B","volume":"1","author":"BR Babu","year":"2003","unstructured":"Babu BR, Keinicke L, Petersen M, Nielsen C, Wengel J (2003) 2\u2032-Spiro ribo- and arabinonucleosides: synthesis, molecular modelling and incorporation into oligodeoxynucleotides. Org Biomol Chem 1:3514\u20133526. \n https:\/\/doi.org\/10.1039\/B306354B","journal-title":"Org Biomol Chem"},{"key":"31_CR129","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1021\/jm401224y","volume":"57","author":"J Du","year":"2014","unstructured":"Du J, Chun BK, Mosley RT, Bansal S, Bao H, Espiritu C, Lam AM, Murakami E, Niu C, Micolochick Steuer HM, Furman PA, Sofia JM (2014) Use of 2\u2032-spirocyclic ethers in HCV nucleoside design. J Med Chem 57:1826\u20131835. \n https:\/\/doi.org\/10.1021\/jm401224y","journal-title":"J Med Chem"},{"key":"31_CR130","doi-asserted-by":"publisher","first-page":"8145","DOI":"10.1016\/j.tet.2010.08.033","volume":"66","author":"K Versteeg","year":"2010","unstructured":"Versteeg K, Zwilling D, Wang H, Church KM (2010) Synthesis, structure, and sugar dynamics of a 2\u2032-spiroisoxazolidine thymidine analog. Tetrahedron 66:8145\u20138150. \n https:\/\/doi.org\/10.1016\/j.tet.2010.08.033","journal-title":"Tetrahedron"},{"key":"31_CR131","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1021\/ol0491989","volume":"6","author":"L Bondada","year":"2004","unstructured":"Bondada L, Gumina G, Nair R, Ning XH, Schinazi RF, Chu CK (2004) Synthesis of novel spiro[2.3]hexane carbocyclic nucleosides via enzymatic resolution. Org Lett 6:2531\u20132534. \n https:\/\/doi.org\/10.1021\/ol0491989","journal-title":"Org Lett"},{"key":"31_CR132","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1021\/jm00093a002","volume":"35","author":"MJ Camarasa","year":"1992","unstructured":"Camarasa MJ, P\u00e9rez-P\u00e9rez MJ, San F\u00e9lix A, Balzarine J, de Clerq E (1992) 3\u2032-Spiro nucleosides, a new class of specific human immunodeficiency virus type 1 inhibitors: synthesis and antiviral activity of [2\u2032,5\u2032-bis-O-(tert-butyldimethylsilyl)-\u03b2-D-xylo- and- ribofuranose]-3\u2032-spiro-5\u2033-[4\u2033-amino-1\u2033-2\u2033-oxathiole 2\u2033, 2\u2033-dioxide] (TSAO) pyrimidine nucleosides. J Med Chem 35:2721\u20132727. \n https:\/\/doi.org\/10.1021\/jm00093a002","journal-title":"J Med Chem"},{"key":"31_CR133","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1073\/pnas.89.10.4392","volume":"89","author":"J Balzarini","year":"1992","unstructured":"Balzarini J, P\u00e9rez-P\u00e9rez MJ, San-F\u00e9lix A, Schols D, Perno CF, Vandamme AM, Camarasa MJ, De Clercq E (1992) 2\u2032,5\u2032-Bis-O-(tert-butyldimethylsilyl)-3\u2032-spiro-5\u2033-(4\u2033-amino-1\u2033,2\u2033-oxathiole-2\u2033,2\u2033-dioxide)pyrimidine (TSAO) nucleoside analogues: highly selective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase. Proc Natl Acad Sci U S A 89:4392\u20134397","journal-title":"Proc Natl Acad Sci U S A"},{"key":"31_CR134","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1021\/jm00094a009","volume":"35","author":"MJ P\u00e9rez-P\u00e9rez","year":"1992","unstructured":"P\u00e9rez-P\u00e9rez MJ, San F\u00e9lix A, Balzarini J, De Clerq E, Camarasa MJ (1992) TSAO analogs. Stereospecific synthesis and anti-HIV-1 activity of 1-[2\u2032,5\u2032-bis-O-(tert-butyldimethylsilyl)-\u03b2-D-ribofuranosyl]-3\u2032-spiro-5\u2033-(4\u2032-amino-1\u2033,2\u2033-oxathiole-2\u2033-2\u2033-dioxide)pyrimidine and pyrimidine-modified nucleosides. J Med Chem 35:2988\u20132995. \n https:\/\/doi.org\/10.1021\/jm00094a009","journal-title":"J Med Chem"},{"key":"31_CR135","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1021\/jm00074a003","volume":"36","author":"S Vel\u00e1zquez","year":"1993","unstructured":"Vel\u00e1zquez S, F\u00e9lix S, P\u00e9rez-P\u00e9rez MJ, Balzarini J, de Clerq E, Camarasa MJ (1993) TSAO analogs. 3. Synthesis and anti-HIV-1. Activity of [2\u2032-5\u2032-bis-O-(tert-butyldimethylsilyl)-\u03b2-D-ribofuranosyl]-3\u2032-spiro-5\u2033-(4\u2032-amino-1\u2033,2\u2033-oxathiole-2\u2033-2\u2033-dioxide)purin and purine-modified nucleosides. J Med Chem 36:3230\u20133239. \n https:\/\/doi.org\/10.1021\/jm00074a003","journal-title":"J Med Chem"},{"key":"31_CR136","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1021\/jm00030a004","volume":"37","author":"A San-F\u00e9lix","year":"1994","unstructured":"San-F\u00e9lix A, Vel\u00e1zquez S, P\u00e9rez-P\u00e9rez MJ, Balzarini J, de Clercq E, Camarasa MJ (1994) Novel series of TSAO-T derivatives. Synthesis and anti-HIV-1 activity of 4-, 5-, and 6-substituted pyrimidine analogs. J Med Chem 37:453\u2013460. \n https:\/\/doi.org\/10.1021\/jm00030a004","journal-title":"J Med Chem"},{"key":"31_CR137","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1021\/jm00050a015","volume":"37","author":"R Alvarez","year":"1994","unstructured":"Alvarez R, Vel\u00e1zquez S, San-F\u00e9lix A, Aquaro S, de Clercq E, Perno CF, Karlsson A, Balzarini J, Camarasa MJ (1994) 1,2,3-Triazole-[2,5-bis-O-(tert-butyldimethylsilyl)-beta.-D-ribofuranosyl]-3\u2032-spiro-5\u2033-(4\u2032-amino-1\u2033,2\u2033-oxathiole-2\u2033-2\u2033-dioxide) (TSAO) analogs: synthesis and anti-HIV-1 activity. J Med Chem 37:4185\u20134194. \n https:\/\/doi.org\/10.1021\/jm00050a015","journal-title":"J Med Chem"},{"key":"31_CR138","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/15257779908041536","volume":"18","author":"E Lobat\u00f3n","year":"1999","unstructured":"Lobat\u00f3n E, Vel\u00e1zquez S, San-F\u00e9lix A, Chamorro C, Tu\u00f1\u00f3n V, Esteban-Gamboa A, de Clercq E, Balzarini J, Camarasa MJ, P\u00e9rez-P\u00e9rez MJ (1999) Novel TSAO derivatives modified at positions 3\u2033 and 4\u2032 of the spiro moiety. Nucleosides Nucleotides 18:675\u2013676. \n https:\/\/doi.org\/10.1080\/15257779908041536","journal-title":"Nucleosides Nucleotides"},{"key":"31_CR139","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1055\/s-2000-7124","volume":"9","author":"E Lobat\u00f3n","year":"2000","unstructured":"Lobat\u00f3n E, Camarasa MJ, Vel\u00e1zquez S (2000) An efficient synthesis of 3\u2032-spiro sultone nucleosides functionalized on the sultone moiety via Pd-catalyzed cross-coupling reaction. Synlett 9:1312\u20131314. \n https:\/\/doi.org\/10.1055\/s-2000-7124","journal-title":"Synlett"},{"key":"31_CR140","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1021\/jm040868q","volume":"48","author":"S Castro de","year":"2005","unstructured":"de Castro S, Lobat\u00f3n E, P\u00e9rez-P\u00e9rez MJ, San-F\u00e9lix A, Cordeiro A, Andrei G, Snoeck R, de Clercq E, Balzarini J, Camarasa MJ, Vel\u00e1zquez S (2005) Novel [2\u2032,5\u2032-bis-O-(tert-butyldimethylsilyl)-\u03b1-D-ribofuranosyl]-3\u2032-spiro-5\u2033-(4\u2033-amino-1\u2033,2\u2033-oxathiole-2\u2033,2\u2033-dioxide) derivatives with anti-HIV-1 and anti-human-cytomegalovirus activity. J Med Chem 48:1158\u20131168. \n https:\/\/doi.org\/10.1021\/jm040868q","journal-title":"J Med Chem"},{"key":"31_CR141","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/15257770008035024","volume":"19","author":"JM Tronchet","year":"2000","unstructured":"Tronchet JM, Kovacs I, Seman M, Dilda P, de Clercq E, Balzarini J (2000) Highly stereoselective synthesis and biological properties of nucleoside analogues bearing a spiro inserted oxirane ring. Nucleosides Nucleotides Nucleic Acids 19:775\u2013779. \n https:\/\/doi.org\/10.1080\/15257770008035024","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"31_CR142","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1016\/j.tet.2009.03.038","volume":"65","author":"C Gash","year":"2009","unstructured":"Gash C, Illagua JM, Merino-Montiel P, Fuentes J (2009) Stereocontrolled synthesis of (5\u00a0+\u00a05), (5\u00a0+\u00a06) and (6\u00a0+\u00a06) 3-spiropseudonucleosides. Tetrahedron 65:4149\u20134155. \n https:\/\/doi.org\/10.1016\/j.tet.2009.03.038","journal-title":"Tetrahedron"},{"key":"31_CR143","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.carres.2013.04.008","volume":"375","author":"M Turks","year":"2013","unstructured":"Turks M, Rodins V, Rolava E, Ostrovskis P, Belyakov S (2013) A practical access to glucose- and allose-based (5\u00a0+\u00a05) 3-spiropseudonucleosides from a common intermediate. Carbohydr Res 375:5\u201315. \n https:\/\/doi.org\/10.1016\/j.carres.2013.04.008","journal-title":"Carbohydr Res"},{"key":"31_CR144","doi-asserted-by":"publisher","unstructured":"Lipshutz BH, Sharma S, Dimock SH, Behling JR (1992) Preparation of C-4 alkylated dideoxyribosides: potential precursors to a novel series of nucleosides. Synthesis 191\u2013195. \n https:\/\/doi.org\/10.1055\/s-1992-34158","DOI":"10.1055\/s-1992-34158"},{"key":"31_CR145","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1021\/jo990046e","volume":"64","author":"D Crich","year":"1999","unstructured":"Crich D, Hao X (1999) Asymmetric synthesis of C4\u2032-\u03b1-carboxylated 2\u2032-deoxynucleosides. Preparation of oxetanone derivatives and influence of solvent on the stereochemistry of base introduction. J Org Chem 64:4016\u20134024. \n https:\/\/doi.org\/10.1021\/jo990046e","journal-title":"J Org Chem"},{"key":"31_CR146","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1021\/ol010209x","volume":"57","author":"LA Paquette","year":"2004","unstructured":"Paquette LA (2004) Spirocyclic restriction of nucleosides. Aust J Chem 57:7\u201317. \n https:\/\/doi.org\/10.1021\/ol010209x","journal-title":"Aust J Chem"},{"key":"31_CR147","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1021\/jo010026o","volume":"66","author":"LA Paquette","year":"2001","unstructured":"Paquette LA, Owen DR, Bibart RT, Seekamp CK, Kahane AL, Lanter JC, Corral MA (2001) 1-Oxaspiro[4.4]nonan-6-ones. Synthetic access via oxonium ion technology, optical resolution, and conversion into enantiopure spirocyclic \u03b1,\u03b2-butenolides. J Org Chem 66:2828\u20132834. \n https:\/\/doi.org\/10.1021\/jo010026o","journal-title":"J Org Chem"},{"key":"31_CR148","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1021\/ol010209x","volume":"3","author":"LA Paquette","year":"2001","unstructured":"Paquette LA, Bibart RT, Seekamp CK, Kahane AL (2001) Spirocyclic restriction of nucleosides. Synthesis of the first exemplary syn-1-oxaspiro[4.4]nonanyl member. Org Lett 3:4039\u20134041. \n https:\/\/doi.org\/10.1021\/ol010209x","journal-title":"Org Lett"},{"key":"31_CR149","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1021\/ol010212g","volume":"3","author":"LA Paquette","year":"2001","unstructured":"Paquette LA, Owen DR, Bibart RT, Seekamp CK (2001) Spirocyclic restriction of nucleosides. An analysis of protecting group feasibility while accessing prototype anti-1-oxaspiro[4.4]nonanyl mimics. Org Lett 3:4043\u20134045. \n https:\/\/doi.org\/10.1021\/ol010212g","journal-title":"Org Lett"},{"key":"31_CR150","doi-asserted-by":"publisher","first-page":"8614","DOI":"10.1021\/jo0301954","volume":"68","author":"LA Paquette","year":"2003","unstructured":"Paquette LA, Seekamp CK, Kahane AL (2003) Conformational restriction of nucleosides by spirocyclic annulation at C4\u2032 including synthesis of the complementary dideoxy and didehydrodideoxy analogues. J Org Chem 68:8614\u20138624. \n https:\/\/doi.org\/10.1021\/jo0301954","journal-title":"J Org Chem"},{"key":"31_CR151","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1021\/jo052324h","volume":"71","author":"S Dong","year":"2006","unstructured":"Dong S, Paquette LA (2006) Highly stereoselective \u03b2-anomeric glycosidation of a 2\u2032-deoxy syn-5\u2032-configured 4\u2032-spironucleoside. J Org Chem 71:1647\u20131652. \n https:\/\/doi.org\/10.1021\/jo052324h","journal-title":"J Org Chem"},{"key":"31_CR152","doi-asserted-by":"publisher","unstructured":"Maity JK, Achari B, Drew MGB, Mandal SB (2010) Synthesis of a carbohydrate-derived 1-oxaspiro[4.4] nonane skeleton and its conversion into spironucleosides. Synthesis 2533\u20132542. \n https:\/\/doi.org\/10.1055\/s-0029-1218828","DOI":"10.1055\/s-0029-1218828"},{"key":"31_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/med.2610060102","volume":"6","author":"VE Marquez","year":"1986","unstructured":"Marquez VE, Lim MI (1986) Carbocyclic nucleosides. Med Res Rev 6:1\u201340","journal-title":"Med Res Rev"},{"key":"31_CR154","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1389557033405331","volume":"3","author":"JB Rodriquez","year":"2003","unstructured":"Rodriquez JB, Comin MJ (2003) New progresses in the enantioselective synthesis and biological properties of carbocyclic nucleosides. Mini-Rev Med Chem 3:95\u2013114. \n https:\/\/doi.org\/10.2174\/1389557033405331","journal-title":"Mini-Rev Med Chem"},{"key":"31_CR155","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2174\/1568026023393228","volume":"2","author":"SW Schneller","year":"2002","unstructured":"Schneller SW (2002) Carbocyclic nucleosides (carbanucleosides) as new therapeutic leads. Curr Top Med Chem 2:1087\u20131092. \n https:\/\/doi.org\/10.2174\/1568026023393228","journal-title":"Curr Top Med Chem"},{"key":"31_CR156","doi-asserted-by":"publisher","first-page":"9229","DOI":"10.1016\/S0040-4020(98)00320-2","volume":"54","author":"MT Crimmins","year":"1998","unstructured":"Crimmins MT (1998) New developments in the enantioselective synthesis of cyclopentyl carbocyclic nucleosides. Tetrahedron 54:9229\u20139272. \n https:\/\/doi.org\/10.1016\/S0040-4020(98)00320-2","journal-title":"Tetrahedron"},{"key":"31_CR157","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1021\/cr00016a004","volume":"92","author":"DM Huryn","year":"1992","unstructured":"Huryn DM, Okabe M (1992) AIDS-driven nucleoside chemistry. Chem Rev 92:1745\u20131768. \n https:\/\/doi.org\/10.1021\/cr00016a004","journal-title":"Chem Rev"},{"key":"31_CR158","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0040-4020(01)88122-9","volume":"48","author":"AD Borthwick","year":"1992","unstructured":"Borthwick AD, Biggadike K (1992) Synthesis of chiral carbocyclic nucleosides. Tetrahedron 48:571\u2013623. \n https:\/\/doi.org\/10.1016\/S0040-4020(01)88122-9","journal-title":"Tetrahedron"},{"key":"31_CR159","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1021\/ol0340033","volume":"5","author":"LA Paquette","year":"2003","unstructured":"Paquette LA, Hartung RE, France DJ (2003) Conversion of the enantiomers of spiro[4.4]nonane-1,6-diol into both epimeric carbaspironucleosides having natural C1\u2032 absolute configuration. Org Lett 5:869\u2013871. \n https:\/\/doi.org\/10.1021\/ol0340033","journal-title":"Org Lett"},{"key":"31_CR160","doi-asserted-by":"publisher","unstructured":"Hartung RE, Paquette LA (2005) Development of a generic stereocontrolled pathway to fully hydroxylated spirocarbocyclic nucleosides as a prelude to RNA targeting. Synthesis 3209\u20133218. \n https:\/\/doi.org\/10.1055\/s-2005-918472","DOI":"10.1055\/s-2005-918472"},{"key":"31_CR161","doi-asserted-by":"publisher","unstructured":"Dyson MR, Coe PL, Walker RT (1991) The synthesis and antiviral properties of E-5-(2-bromovinyl)-4\u2032-thio-2\u2032-deoxyuridine. J Chem Soc Chem Commun 741\u2013742. doi:\n https:\/\/doi.org\/10.1039\/c39910000741","DOI":"10.1039\/c39910000741"},{"key":"31_CR162","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1080\/15257779408009484","volume":"13","author":"KN Tiwari","year":"1994","unstructured":"Tiwari KN, Seacrist JA, Montgomery JA (1994) Synthesis and biological activity of 4\u2032-thionucleosides of 2-chloroadenine. Nucleosides Nucleotides 13:1819\u20131828. \n https:\/\/doi.org\/10.1080\/15257779408009484","journal-title":"Nucleosides Nucleotides"},{"key":"31_CR163","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1016\/0960-894X(95)00472-6","volume":"5","author":"RJ Young","year":"1995","unstructured":"Young RJ, Shae-Ponter S, Thomson JB, Miller JA, Cumming JG, Pugh AW, Rider P (1995) Synthesis and antiviral evaluation of enantiomeric 2\u2032,3\u2032-dideoxy- and 2\u2032,3\u2032-didehydro-2\u2032,3\u2032-dideoxy-4\u2032-thionucleosides. Bioorg Med Chem Lett 5:2599\u20132604. \n https:\/\/doi.org\/10.1016\/0960-894X(95)00472-6","journal-title":"Bioorg Med Chem Lett"},{"key":"31_CR164","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1021\/jm9701536","volume":"40","author":"Y Yoshimura","year":"1997","unstructured":"Yoshimura Y, Watanabe M, Satoh H, Ashida N, Ijichi K, Sakata S, Machida H, Matsuda A (1997) A facile, alternative synthesis of 4\u2032-thioarabinonucleosides and their biological activities. J Med Chem 40:2177\u20132183. \n https:\/\/doi.org\/10.1021\/jm9701536","journal-title":"J Med Chem"},{"key":"31_CR165","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/07328319808005158","volume":"17","author":"H Satoh","year":"1998","unstructured":"Satoh H, Yoshimura Y, Watanabe M, Ashida N, Ijichi K, Sakata S, Machida H (1998) Synthesis and antiviral activities of 5-substituted 1-(2-deoxy-2-C-methylene-4-thio-\u03b2-D-erythro-pentofuranosyl)uracil. Nucleosides Nucleotides 17:65\u201379. \n https:\/\/doi.org\/10.1080\/07328319808005158","journal-title":"Nucleosides Nucleotides"},{"key":"31_CR166","doi-asserted-by":"publisher","first-page":"8625","DOI":"10.1021\/jo030196w","volume":"68","author":"LA Paquette","year":"2003","unstructured":"Paquette LA, Fabris F, Gallou F, Dong S (2003) C4\u2032-Spiroalkylated nucleosides having sulfur incorporated at the apex position. J Org Chem 68:8625\u20138634. \n https:\/\/doi.org\/10.1021\/jo030196w","journal-title":"J Org Chem"},{"key":"31_CR167","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1016\/j.tetlet.2006.03.175","volume":"47","author":"A Roy","year":"2006","unstructured":"Roy A, Achari B, Mandal SB (2006) An easy access to spiroannulated glyco-oxetane, -thietane and -azetane rings: synthesis of spironucleosides. Tetrahedron Lett 47:3875\u20133879. \n https:\/\/doi.org\/10.1016\/j.tetlet.2006.03.175","journal-title":"Tetrahedron Lett"},{"key":"31_CR168","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1021\/jo8002826","volume":"73","author":"SB Mandal","year":"2008","unstructured":"Mandal SB (2008) Introduction of vinyl and hydroxymethyl functionalities at C-4 of glucose-derived substrates: synthesis of spirocyclic, bicyclic, and tricyclic nucleosides. J Org Chem 73:4305\u20134308. \n https:\/\/doi.org\/10.1021\/jo8002826","journal-title":"J Org Chem"},{"key":"31_CR169","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.tetlet.2008.11.039","volume":"50","author":"GSG Carvalho de","year":"2009","unstructured":"de Carvalho GSG, Fourrey JL, Dodd RH, Da Silva AD (2009) Synthesis of a 4\u2032,4\u2032-spirothietane-2\u2032, N3-cycloadenosine as a highly constrained analogue of 5\u2032-deoxy-5\u2032-methylthioadenosine (MTA). Tetrahedron Lett 50:463\u2013466. \n https:\/\/doi.org\/10.1016\/j.tetlet.2008.11.039","journal-title":"Tetrahedron Lett"},{"key":"31_CR170","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1021\/jo070846m","volume":"72","author":"S Tripathi","year":"2007","unstructured":"Tripathi S, Roy BG, Drew MG, Achari B, Mandal SB (2007) Synthesis of oxepane ring containing monocyclic, conformationally restricted bicyclic and spirocyclic nucleosides from D-glucose: a cycloaddition approach. J Org Chem 72:7427\u20137430. \n https:\/\/doi.org\/10.1021\/jo070846m","journal-title":"J Org Chem"},{"key":"31_CR171","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1074\/jbc.M510195200","volume":"281","author":"K Klumpp","year":"2006","unstructured":"Klumpp K, L\u00e9v\u00eaque V, Le Pogam S, Ma H, Jiang WR, Kang H, Granycome C, Singer M, Laxton C, Hang JQ, Sarma K, Smith DB, Heindl D, Hobbs CJ, Merrett JH, Symons J, Cammack N, Martin JA, Devos R, N\u00e1jera I (2006) The novel nucleoside analog R1479 (4\u2032-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture. J Biol Chem 281:3793\u20133799. \n https:\/\/doi.org\/10.1074\/jbc.M510195200","journal-title":"J Biol Chem"},{"key":"31_CR172","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1016\/j.tetlet.2014.06.029","volume":"55","author":"Q Dang","year":"2014","unstructured":"Dang Q, Zhang Z, He S, Liu Y, Chen T, Bogen S, Girijavallabhan V, Olsen DB, Meinke PT (2014) Syntheses of 4\u2032-spirocyclic phosphono-nucleosides as potential inhibitors of hepatitis C virus NS5B polymerase. Tetrahedron Lett 55:4407\u20134409. \n https:\/\/doi.org\/10.1016\/j.tetlet.2014.06.029","journal-title":"Tetrahedron Lett"}],"container-title":["Topics in Heterocyclic Chemistry","Carbohydrate-spiro-heterocycles"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/7081_2019_31","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T20:12:50Z","timestamp":1572120770000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/7081_2019_31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030319410","9783030319427"],"references-count":172,"URL":"https:\/\/doi.org\/10.1007\/7081_2019_31","relation":{},"ISSN":["1861-9282","1861-9290"],"issn-type":[{"type":"print","value":"1861-9282"},{"type":"electronic","value":"1861-9290"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"24 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}